| 59.4% |  | United States |
| 8.7% |  | United Kingdom |
| 5% |  | Canada |
| 4% |  | Australia |
| 3.5% |  | Philippines |
| 2.6% |  | Netherlands |
| 2.4% |  | India |
| 1.6% |  | Germany |
| 1% |  | France |
| 0.7% |  | Poland |
| Today: | 211 |
| Yesterday: | 251 |
| This Week: | 211 |
| Last Week: | 2221 |
| This Month: | 4799 |
| Last Month: | 6796 |
| Total: | 129398 |
7. Information on any assessment of mephedrone in the United Nations system
Written by EMCDDA | 
| 
| 
| Reports - EMCDDA Report on the risk assessment of mephedrone |
Drug Abuse
The World Health Organization (WHO) is the specialised UN agency designated for the evaluation of medical, scientific and public-health aspects of psychoactive substances under the 1961 and 1971 UN Conventions. The WHO informed the EMCDDA that 4-methylmethcathinone (mephedrone) is currently not under assessment and has not been under assessment by the UN system.
| < Prev | Next > |
|---|